BioMarin Announces Updated Strategy for ROCTAVIAN® to Focus on U.S., Germany and Italy
Go back to BioMarin Announces Updated Strategy for ROCTAVIAN® to Focus on U.S., Germany and Italy| BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) | Delayed: 55.90 +1.21 (2.21%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $54.69 | 52 Week High | $108.96 | |||
| Open | $55.51 | 52 Week Low | $62.12 | |||
| Day High | $56.31 | P/E | N/A | |||
| Day Low | $54.96 | EPS | $-1.27 | |||
| Volume | 2,992,166 | |||||
